Tumor Diagnosis

Tumor Diagnosis

ELISA: CA 72-4
CA 72-4 (Cancer antigen 72-4) was originally described as an antigenic determinant recognized by B 72.3, a murine monoclonal antibody raised against a membrane extract of mamacarcinoma metastasases. Elevated CA 72-4 levels in serum and plasma have been reported in various malignant diseases including carcinomas of pancreas, stomach, gall, colon, mamma, ovaries, cervix and endometrium. There is a good correlation between CA 72-4 levels and tumor stage and size. CA 72-4 is the marker of choice for the therapeutic monitoring and follow-up care of gastrointestinal cancer patients. Suitable second markers are CA 19-9 or CEA. Additionally, CA 72-4 has been used as an independent marker for the therapeutic monitoring and follow-up care of ovarian cancer patients, in particular in CA 125 negative patients.

Highlight:
CYR61 ELISA
Periostin ELISA

ELISA: Cyfra 21-1
Cytokeratin 19 is expressed in most body tissues. Cyfra 21-1 levels are therefore elevated in many cancer forms. It is predominantly used for the management of patients suffering from lung cancer. It is particularly helpful in the differential diagnosis of bronchial carcinoma.

	PRODUCT		METHOD		CAT NO.		QUANTITY		INCUBATION TIME		REQUEST

Diagnostics that perform

Blutanalyse

Corporate Brochure & Video

Corporate Brochure & Video

Link to Corporate Brochure & Video

News

10-Feb-2025 New Product Catalog of DRG´s Immunoassays
is ready for download! More...

02-Feb-2025 Press Release, Jan. 31, 2025
DRG Is Launching Innovative Traumatic Brain Injury (TBI) Test Panel at MEDLAB in Dubai More...

31-Jan-2025 NEW BROCHURE
Iron Metabolism: Hepcidin 25 More...

28-Jan-2025 Spotlight to our UNIQUE product:
CMV IgG Buccal Swab ELISA More...

27-Jan-2025 NEW BROCHURE
Fecal Calprotectin - Fully automated with DRG:HYBRiD-XL Analyzer More...

24-Jan-2025 NEW BROCHURE
Fecal Pancreatic Elastase - Fully automated with DRG:HYBRiD-XL Analyzer More...

13-Jan-2025 DRG will be exhibiting at MEDLAB Middle East 2025 in Dubai
More...

20-Dec-2024 DRG is introducing electronic Instruction for Use (eIFU)
More...

22-Oct-2024 Meet DRG and BioCheck at MEDICA 2024
More...

11-Sep-2024 Exciting News from DRG:
IMPROVED Calprotectin (stool) fully automated on DRG:HYBRiD-XL More...

02-Aug-2024 DRG and BioCheck participated together at ADLM 2024 in Chicago

We thank all visitors and guests! More...

02-Apr-2024 Installation of DYNEX DSX-Analyzer at DRGs distributor A.T.M. Importadora in Cochabamba, Bolivia
More...

14-Mar-2024 DRG has re-established the distribution partnership with MERCODIA for the German market
More...

18-Jan-2024 Meet DRG at Medlab Middle East in Dubai, February 5-8
More...

24-Nov-2023 Review our New Infectious Diseases ELISAs Brochure
More...

3-Nov-2023 Our new brochure CMV IgG Buccal Swab ELISA is available!
Get your own copy! More...

23-Oct-2023 DRG will be at MEDICA again!
Meet us in hall 3, booth A69 More...

29-Sep-2023 Meet DRG at the DKLM Congress in Mannheim, Germany
More...

28-Sep-2023 Diagnostics-4-Future Conference
DRG is official partner on this Conference in Konstanz, October 17-18 More...

27-Sep-2023 Spotlight to CMV IgG Buccal Swab ELISA
Learn about DRG´s UNIQUE test More...

05-Sep-2023 Meet DRG at Medic West Africa 2023
26-28 September 2023 | Lagos, Nigeria More...

17-Jul-2023 Meet DRG and BioCheck at AACC 2023
Booth #573 in Hall D More...

30-Jun-2023 Spotlight to DRGs 17-OH Progesterone ELISA
Read more about this important diagnostic tool More...

24-Apr-2023 Come to meet DRG at Euromedlab 2023
21 - 25 May in Rome More...

31-Mar-2023 Spotlight to DRG´s DHT-optimized ELISA
Read more about one of DRG´s bestsellers More...

13-Jan-2023 Meet DRG at Medlab Middle East in Dubai, February 6-9
More...

Certificate

Certificate

EN-ISO-13485-2016 DE
EN-ISO-13485-2016 EN
List B Products EN

© DRG INSTRUMENTS GMBH, DEUTSCHLAND

Privacy Preferences | Privacy Policy | Cookie Policy | IMPRINT | CONTACT